BR0205104A - Composição hormonal inédita e sua utilização - Google Patents

Composição hormonal inédita e sua utilização

Info

Publication number
BR0205104A
BR0205104A BR0205104-4A BR0205104A BR0205104A BR 0205104 A BR0205104 A BR 0205104A BR 0205104 A BR0205104 A BR 0205104A BR 0205104 A BR0205104 A BR 0205104A
Authority
BR
Brazil
Prior art keywords
estrogen
gestagen
hormonal
combination
compound
Prior art date
Application number
BR0205104-4A
Other languages
English (en)
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of BR0205104A publication Critical patent/BR0205104A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMPOSIçãO HORMONAL INéDITA E SUA UTILIZAçãO". A presente invenção se refere ao campo da química terapêutica e mais especificamente ao campo das técnica farmacêutica hormonal. Ela tem mais exatamente por objetivo composições farmacêuticas hormonais inéditas formadas por uma associação estro-gestagênica constituída por um composto estrogênico e por um composto gestagênico em associação ou em mistura com um ou mais excipientes não tóxicos, inertes, aceitáveis do ponto de vista farmacêutico, destinados à administração por via oral. A presente invenção se refere também à utilização da mistura estro-gestagênica na qual o componente estrogênico e o composto gestagênico são administrados de modo combinado. A associação combinada pode ser prescrita de modo contínuo ou descontínuo, tendo-se em vista a produção de uma composição destinada a tratar as carências estrogênicas, e a prevenir a osteoporose e as doenças cardiovasculares na mulher após a menopausa. A invenção tem ainda por objetivo um processo de preparação destas composições farmacêuticas estro-gestagênicas inéditas.
BR0205104-4A 2001-04-25 2002-04-23 Composição hormonal inédita e sua utilização BR0205104A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105557A FR2823976A1 (fr) 2001-04-25 2001-04-25 Nouvelle composition hormonale et son utilisation
PCT/FR2002/001384 WO2002085375A1 (fr) 2001-04-25 2002-04-23 Nouvelle composition hormonale et son utilisation

Publications (1)

Publication Number Publication Date
BR0205104A true BR0205104A (pt) 2003-05-20

Family

ID=8862668

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0205104-4A BR0205104A (pt) 2001-04-25 2002-04-23 Composição hormonal inédita e sua utilização

Country Status (9)

Country Link
KR (1) KR20030043797A (pt)
CN (1) CN1464787A (pt)
AR (1) AR033260A1 (pt)
AU (1) AU2002310721A1 (pt)
BR (1) BR0205104A (pt)
FR (1) FR2823976A1 (pt)
MA (1) MA26833A1 (pt)
NO (1) NO20026215L (pt)
WO (1) WO2002085375A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022053B2 (en) 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
UY29185A1 (es) * 2004-11-02 2006-05-31 Schering Ag Formas de dosificación oral sólidas que contienen una dosis baja de estradiol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation

Also Published As

Publication number Publication date
MA26833A1 (fr) 2004-12-20
AR033260A1 (es) 2003-12-10
NO20026215D0 (no) 2002-12-23
KR20030043797A (ko) 2003-06-02
WO2002085375A1 (fr) 2002-10-31
FR2823976A1 (fr) 2002-10-31
AU2002310721A1 (en) 2002-11-05
WO2002085375A8 (fr) 2003-02-20
NO20026215L (no) 2003-02-21
CN1464787A (zh) 2003-12-31

Similar Documents

Publication Publication Date Title
DE69022722T2 (de) Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen.
US9084796B2 (en) Hormonal composition and its use
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
BR0111186A (pt) Uso de composição de celecoxib para rápido alìvio de dor
BR122014001142B8 (pt) processo de produzir uma formulação em comprimido purgativa colônica para administração oral
JP2008512426A5 (pt)
IL172602A0 (en) Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]- octane-3-carboxylic acid deriv atives
GB2395434A (en) Composition for reducing appetite in mammals comprising proxyanidin
JP2005516904A5 (pt)
ATE452641T1 (de) Orale pharmazeutische zusammensetzung enthaltend 15-hydroxytestosteron und seine derivate
BR9712274A (pt) Composição hormonal consistindo de um composto de estrogênio e um composto progestacional
HUP0300709A2 (hu) Pemetrexedet monotioglikollal, L-ciszteinnel vagy tioglikolsavval együtt tartalmazó gyógyászati készítmény
BR0313494A (pt) Métodos de administração e realce da absorção de agentes farmacêuticos
IL120558A (en) Hormonal drugs and their uses for repairing estrogen deficiencies
JPH04210924A (ja) カルシトニンの経口投与用の製薬組成物及び投薬形態
BR0205104A (pt) Composição hormonal inédita e sua utilização
MXPA04012410A (es) Composiciones, formulaciones y equipo para el tratamiento de enfermedades pulmonares y respiratorias con deshidroepiandrosteronas, esteroides y agentes antimuscarinicos.
BR0014952A (pt) Medicamento contraceptivo e seu modo de preparação
BRPI0410707A (pt) composição que compreende antagonistas de receptores de progesterona e antiestrogênios puros para a profilaxia e tratamento de doenças dependentes de hormÈnios
BR0115506A (pt) Composições farmacêuticas tendo uma ação antidiabética, e processo para sua preparação
FR2769839B1 (fr) Composition anhydre a base de lactulose
US4105794A (en) Process of mitigating cholelithiasis
BR0300434A (pt) Composição farmacêutica oral, utilizada como antiespasmódico geral do músculo liso com aplicações biliares, digestivas, urinárias e ginecológicas, e no tratamento da cólica intestinal moderada a severa, e, uso da mesma
CR6628A (es) Nueva composicion hormonal y su utilizacion
CN1989977A (zh) 一种特效脚癣药粉

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired